Pilot study indicated 300 mg of Robuvit daily for four weeks significantly improved vigor and related mental and mood attributes compared to a control group.
In a clinical study, Affron supplementation presented self-reported improvements in anxiety and depression symptoms in teens over an eight-week period.
In recognition of the 50th anniversary of Earth Day, the nonprofit organization published guidance on best practices for the environment and social equity.
An in vivo study conducted on Pharmactive Biotech’s ABG10+, with high SAC and polyphenols, showed improvements to several cardiovascular health metrics in rats.
Sales of cannabidiol-based products have soared during the past year, and now formulators are rolling out CBD products designed to ease a variety of ailments.
Two types of cannabinoid receptors have been identified in human cells. Keratinocytes contain both, justifying interest in CBD among cosmetic companies.
By Paolo U Giacomoni, PhD, Insight Analysis Consulting 04.02.20
A flood of all types of consumer products in the marketplace warrants a review of available scientific evidence.
By Marilyn Barrett, PhD, Pharmacognosy Consulting, Inc., Mary Ellen Cosenza, PhD, MEC Regulatory & Toxicology Consulting, Steven Dentali, PhD, Dentali Botanical Sciences, and Sandy Bigelow, PhD, Vanguard Global Associates LLC04.02.20